Thus, given that both STAT3 and β-catenin are activated in a subset of breast tumors, it was hypothesized that STAT3 may provide a further mechanism by which β-catenin is regulated in breast cancer cells [74]. The gene discussed is STAT3; the disease is breast carcinoma.